リリーはインシリコ・メディシーと AI薬の開発契約を結んだ. Lilly partners with Insilico Medicine for AI drug development deal.

エライ・リリーは 香港のインシリコメディシーと 25億ドル規模の契約を締結し AIを使って薬の開発に合意しました Eli Lilly has agreed to a potential $2.75 billion deal with Hong Kong-based Insilico Medicine to use AI for drug discovery. リリーはインシリコが開発した薬の開発の権利を獲得し, インシリカは1億1500万ドルを前払いして, 薬の成功に基づいて追加支払いを受ける. Lilly will gain rights to develop drugs created by Insilico, which uses artificial intelligence to design new therapies, while Insilico receives an upfront payment of $115 million and additional payments based on the drugs' success.